Application note: LlaMAbody™ camelid antibodies flyer
Single-domain antibodies (sdAb) are small, stable antibodies derived from camelids with a single monomeric variable domain.
List view / Grid view
Single-domain antibodies (sdAb) are small, stable antibodies derived from camelids with a single monomeric variable domain.
The World Health Organization has declared monkeypox a Public Health Emergency of International Concern, the highest level of alert.
Find western blot application protocols and troubleshooting tips for detecting proteins in this handbook.
Droplet Digital PCR (ddPCR) offers greater accuracy and precision in quantifying viral titer in gene therapies.
View markers for human immune cell characterisation by flow cytometry in relevant cell subsets including B Cells, T Cells, NK Cells and ILCs.
The findings have enabled researchers to design antibodies to activate important receptors on immune cells and deliver more powerful anti-cancer effects.
This infographic will explore Mycoplasma contamination in cell cultures and the best technologies for detection.
Researchers have found that a combination therapy that incorporates a plant virus with an immune cell-activating antibody clears colon cancer in mice.
Scientists have identified a new treatment combination that is highly effective at suppressing the growth of head and neck tumours.
Here Bio-Rad presents the generation of specific anti-CAR T-cell antibodies to show how CAR T-cell analysis benefits from our modular antibody assembly technology using SpyTag-SpyCatcher protein ligation.
An easy-to-follow guide to flow cytometry that is well suited for researchers new to the technique, or experienced scientists looking for a refresher.
A new study in mice has shown blood cancer treatment with protein interleukin-7 revs up T-cell immunotherapy.
New research has found that microbial fermentation of dietary fibre in the gut can protect against allergic skin diseases.
Podcast discussion featuring CAR-T Cell therapy development and reviewing current challenges and future potentials for these cell therapies.
Researchers have developed an immunotherapy platform to improve both antitumor immune responses and responses to checkpoint inhibitors